5Rivers EC, Mancera RL. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action. Drug Discov Today, 2008, 13 : 1090-1098.
6Bashiri G, Squire C J, Moreland N J, et al. Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate binding. J Biol Chem, 2008, 283 : 17531-17541.
7Singh R, Manjunatha U, Boshoff HI, et al. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science, 2008, 322:1392-1395.
8Okada M, Kobayashi K. Recent progress in mycobacteriology. Kekkaku, 2007, 82:783-799.
9Matsumoto M, Hashizume H, Tomishige T, et al. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Med, 2006, 3: e466.
10Haagsma AC, Abdillahi-Ibrahim R, Wagner MJ. Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue. Antimicrob Agents Chemother, 2009, 53 : 1290-1292.
